J&J, Bayer Accused of Hiding Blood-Thinning Drug's Flaws
- First trial begins accusing companies of flawed warnings
- Xarelto is top seller for Bayer and third best for J&J
This article is for subscribers only.
Joseph Boudreaux says taking Johnson & Johnson’s blood-thinning drug Xarelto was one of the biggest mistakes of his life.
While Xarelto was supposed to help cut his stroke risk, Boudreaux says it instead caused internal bleeding that required a week-long hospital stay in the intensive-care unit, several blood transfusions and multiple heart procedures. “I don’t want anybody else to suffer like I have from that drug,” the part-time security guard says.